Results 71 to 80 of about 8,840 (216)

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Disconnected and overconnected nodes in NMOSD patients.

, 2019
Cortical surface representation of the difference in mean global efficiency, clustering, and degree between patient and volunteer groups (in red significantly increased parameter in NMOSD patients compared with healthy subjects, and in blue significantly
Stéphane Kremer (303296), Céline Hemmert (6274130), Sophie Achard (24189), Laurent Kremer (37664), Seyyid Baloglu (6274133), Nicolas Collongues (327353), Kévin Bigaut (6274127), Jérôme De Sèze (6085550)   +7 more
core   +1 more source

Table_1_Enlarged perivascular spaces, neuroinflammation and neurological dysfunction in NMOSD patients.docx

, 2022
Background and objectivesCerebrospinal fluid (CSF) and interstitial fluid exchange along a brain-wide network of perivascular spaces (PVS) termed the ‘glymphatic system’.
Shu-Wei Bai (13878644), Li Xie (108913), Yi-Fan Wu (176590), Chun-Ran Xue (13878650), Mei-Chun Gao (13878641), Yang-Tai Guan (785378), Ya-Ying Song (13878647), Yong Hao (1943506), Jie Ding (73711), Xiao-Ying Yao (13878638), Ying Zhang (40767)   +10 more
core   +1 more source

Short segment myelitis as the initial and only manifestation of aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorders

Therapeutic Advances in Neurological Disorders, 2020
Background: Short segment myelitis (SSM, < 3 vertebral segments) is an under-recognized initial manifestation of neuromyelitis optica spectrum disorders (NMOSD).
Wei Fang*, Yang Zheng*, Fan Yang, Meng-Ting Cai, Chun-Hong Shen, Zhi-Rong Liu, Yin-Xi Zhang, Mei-Ping Ding   +7 more
doaj   +1 more source

The immunological landscape of the area postrema in neuromyelitis optica spectrum disorders

Brain Pathology, EarlyView.
Aquaporin‐4 antibody‐positive neuromyelitis spectrum disorder is characterized by large tissue destructive lesions in medulla, spinal cord, and optic nerves, with only partial recovery from clinical symptoms, and by lesions with very little tissue destruction and mostly complete recovery from clinical symptoms, as seen in the area postrema ...
Qian Yu, Yoshiki Takai, Naoya Yamazaki, Sarah Brandl, Katharina M. Mair, Thibault Bouderlique, Maria Eleni Kastriti, Igor Adameyko, Romana Höftberger, Markus Reindl, Jan Bauer, Monika Bradl   +11 more
wiley   +1 more source

IL-33 relieves nerve injury by mediating microglial polarization in neuromyelitis optica spectrum disorders via the IL-33/ST2 pathway

IBRO Neuroscience Reports
Interleukin-33 (IL-33) is a member of the interleukin-1 cytokine family. Its function in regulating microglial M1/M2 polarization in neuromyelitis optica spectrum disorder (NMOSD) is still unelucidated.
Lu Huang, Congcong Fu, Sha Liao, Youming Long   +3 more
doaj   +1 more source

Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery

Metabolites, 2020
There is no specific test for diagnosing neuromyelitis optica spectrum disorder (NMOSD), a disabling autoimmune disease of the central nervous system. Instead, diagnosis relies on ruling out other related disorders with overlapping clinical symptoms.
Maxton E. Thoman, Susan C. McKarns
doaj   +1 more source

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors

Internal Medicine Journal, EarlyView.
Abstract Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence‐based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or planning to receive, complement inhibitors for neurological conditions in the Australian setting.
Katherine A. Buzzard, Michael Barnett, Heidi Beadnall, Mirasol Forcadela, Lesley‐Ann Hall, Victoria G. Hall, Todd Hardy, Danny Hsu, Paul Kinsella, Mastura Monif, Sudarshini Ramanathan, Stephen W. Reddel, Sean Riminton, Douglas F. Johnson   +13 more
wiley   +1 more source

Induction of immune tolerance in NMOSD and MOGAD

Therapeutic Advances in Neurological Disorders
Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are autoimmune diseases characterized by immune-mediated damage to the central nervous system. Current treatments primarily focus on chronic immunosuppression.
Jorge Correale, Edgar Carnero Contentti
openaire   +4 more sources

Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study

Clinical Ophthalmology, 2022
Busayanut Puangsricharoen,1 Kavin Vanikieti,1 Panitha Jindahra,2 Tanyatuth Padungkiatsagul1 1Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Department of Medicine, Faculty of Medicine ...
Puangsricharoen B, Vanikieti K, Jindahra P, Padungkiatsagul T   +3 more
doaj